Mister Spex Valuation

Is MRX undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of MRX when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate MRX's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate MRX's fair value for valuation analysis.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for MRX?

Key metric: As MRX is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for MRX. This is calculated by dividing MRX's market cap by their current revenue.
What is MRX's PS Ratio?
PS Ratio0.2x
Sales€226.27m
Market Cap€53.50m

Price to Sales Ratio vs Peers

How does MRX's PS Ratio compare to its peers?

The above table shows the PS ratio for MRX vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average1.5x
BIKE Bike24 Holding
0.2x6.5%€54.1m
ART Artnet
1.8xn/a€39.7m
WFA Weng Fine Art
3.6xn/a€21.0m
DOU Douglas
0.5x6.2%€2.0b
MRX Mister Spex
0.2x2.6%€53.5m

Price-To-Sales vs Peers: MRX is good value based on its Price-To-Sales Ratio (0.2x) compared to the peer average (1.5x).


Price to Sales Ratio vs Industry

How does MRX's PS Ratio compare vs other companies in the DE Specialty Retail Industry?

4 CompaniesPrice / SalesEstimated GrowthMarket Cap
CEC Ceconomy
0.06x1.1%US$1.58b
GFG Global Fashion Group
0.07x-0.5%US$57.83m
DEX Delticom
0.07x2.7%US$35.64m
49S Superdry
0.004x-1.4%US$3.12m
No more companies available in this PS range
MRX 0.2xIndustry Avg. 0.4xNo. of Companies5PS00.40.81.21.62+
4 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: MRX is good value based on its Price-To-Sales Ratio (0.2x) compared to the European Specialty Retail industry average (0.4x).


Price to Sales Ratio vs Fair Ratio

What is MRX's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

MRX PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.2x
Fair PS Ratio0.08x

Price-To-Sales vs Fair Ratio: MRX is expensive based on its Price-To-Sales Ratio (0.2x) compared to the estimated Fair Price-To-Sales Ratio (0.1x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst MRX forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€1.54
€5.21
+239.6%
40.4%€7.00€1.85n/a4
Nov ’25€2.08
€5.63
+170.4%
34.6%€7.00€2.30n/a4
Oct ’25€2.27
€5.70
+151.1%
30.7%€7.00€2.30n/a5
Sep ’25€2.57
€5.70
+121.8%
30.7%€7.00€2.30n/a5
Aug ’25€2.85
€6.30
+121.1%
30.8%€9.00€3.00n/a5
Jul ’25€2.82
€6.30
+123.4%
30.8%€9.00€3.00n/a5
Jun ’25€3.29
€6.26
+90.3%
32.1%€9.00€2.80n/a5
May ’25€2.88
€7.00
+143.1%
29.4%€9.00€3.40n/a5
Apr ’25€3.23
€7.08
+119.0%
30.4%€10.00€3.35n/a6
Mar ’25€3.94
€7.22
+83.4%
29.0%€10.00€3.50n/a6
Feb ’25€3.44
€6.73
+95.6%
33.9%€10.00€3.50n/a7
Jan ’25€3.16
€6.74
+113.7%
33.7%€10.00€3.20n/a7
Dec ’24€2.71
€6.74
+149.3%
33.7%€10.00€3.20n/a7
Nov ’24€2.83
€6.86
+142.3%
37.0%€11.00€3.00€2.087
Oct ’24€3.35
€7.00
+109.0%
33.4%€11.00€4.00€2.277
Sep ’24€3.87
€7.00
+81.1%
33.4%€11.00€4.00€2.577
Aug ’24€3.99
€7.09
+77.6%
31.5%€11.00€4.20€2.857
Jul ’24€3.17
€7.09
+123.9%
31.5%€11.00€4.20€2.827
Jun ’24€3.63
€6.88
+89.6%
37.8%€11.00€3.60€3.296
May ’24€3.95
€8.02
+103.2%
48.2%€15.00€4.20€2.886
Apr ’24€3.96
€8.32
+110.0%
45.7%€15.00€4.00€3.236
Mar ’24€3.98
€8.43
+112.2%
43.7%€15.00€4.00€3.946
Feb ’24€3.95
€8.43
+113.5%
43.7%€15.00€4.00€3.446
Jan ’24€4.03
€8.35
+107.5%
46.7%€15.00€4.00€3.166
Dec ’23€4.50
€8.60
+91.3%
44.4%€15.00€4.00€2.716
Nov ’23€3.39
€8.55
+152.6%
51.3%€15.00€4.00€2.836

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.


Discover undervalued companies